Cooper, D., Moisan, J., Abdous, B., & Grégoire, J.-P. (2018). A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA. Journal of Population Therapeutics and Clinical Pharmacology, 15(3). Retrieved from https://jptcp.com/index.php/jptcp/article/view/229